Two Sigma Advisers’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,337
| Closed | -$732K | – | 2321 |
|
|
2025
Q1 | $732K | Buy |
8,337
+3,948
| +90% | +$347K | ﹤0.01% | 1610 |
|
|
2024
Q4 | $407K | Buy |
4,389
+1,220
| +38% | +$113K | ﹤0.01% | 1856 |
|
|
2024
Q3 | $232K | Buy |
3,169
+1,175
| +59% | +$85.9K | ﹤0.01% | 2013 |
|
|
2024
Q2 | $116K | Buy |
1,994
+1,771
| +794% | +$103K | ﹤0.01% | 2303 |
|
|
2024
Q1 | $231K | Buy |
+223
| New | +$231K | ﹤0.01% | 2167 |
|